Literature DB >> 2784850

Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.

J D Haley1, J J Hsuan, M D Waterfield.   

Abstract

Activation of the EGF receptor (c-erbB) tyrosine kinase has been implicated in tumorigenesis, either by overexpression of the normal receptor in the presence of EGF, or through expression of a truncated receptor lacking the EGF binding domain as in the viral oncogene v-erbB. Here, normal and truncated human EGF receptors expressed in Rat1 fibroblasts were analysed for receptor tyrosine kinase activity and several transformation parameters in comparison with polyoma middle T and EJ-ras. Expression of a truncated EGF receptor lacking the extracellular ligand binding domain induced transformation of immortalized rodent fibroblasts and appears to activate the intrinsic tyrosine kinase. The transformed phenotype becomes enhanced by further truncation of the C-terminal domain containing the tyrosine autophosphorylation sites P1 and P2. Over expression of EGF receptors with an intact extracellular region in transfected Rat1 cells shows EGF dependent transformation, which is reduced by C-terminal truncation. Transformation is dependent on the cellular receptor concentration and can be selected as a stable phenotype. We conclude that expression of receptors with a truncated EGF-binding domain alone is sufficient to transform mammalian fibroblasts, in contrast to chick fibroblasts transformed by v-erbB where additional deletion of C-terminal receptor sequences appears to be an absolute requirement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784850

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

Authors:  N Sugawa; A J Ekstrand; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 2.  Will kinase inhibitors make it as glioblastoma drugs?

Authors:  Ingo K Mellinghoff; Nikolaus Schultz; Paul S Mischel; Timothy F Cloughesy
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.

Authors:  A J Ekstrand; N Sugawa; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Structural alterations of the epidermal growth factor receptor gene in human gliomas.

Authors:  A J Wong; J M Ruppert; S H Bigner; C H Grzeschik; P A Humphrey; D S Bigner; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 6.  Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.

Authors:  D M O'Rourke; M I Greene
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Relationships linking amplification level to gene over-expression in gliomas.

Authors:  Nicolas Vogt; Anne Gibaud; Anna Almeida; Isabelle Ourliac-Garnier; Michelle Debatisse; Bernard Malfoy
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

8.  Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.

Authors:  L Hubler; P S Leventhal; P J Bertics
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

9.  A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Authors:  R Nishikawa; X D Ji; R C Harmon; C S Lazar; G N Gill; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

10.  Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses.

Authors:  W Li; N Hack; B Margolis; A Ullrich; K Skorecki; J Schlessinger
Journal:  Cell Regul       Date:  1991-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.